ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1986

Impaired Endothelial Function in Post-Menopausal Women with Osteoporosis

Auleen M. Millar1, Aaron McCann2, Vivian McClenaghan2, Paul Hamilton2, Caroline Bleakley2, Kristopher Lyons2 and Gary McVeigh2, 1Rheumatology, Musgrave Park Hospital, Belfast, United Kingdom, 2Department of Therapeutics and Pharmacology, Belfast, United Kingdom

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease and osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Although traditionally viewed as separate disease entities that increase in prevalence with aging, accumulating evidence indicates that similar pathophysiological mechanisms may underlie cardiovascular disease and osteoporosis. Endothelial dysfunction is the initial step in the atherosclerotic process. The aims of this study were to determine if women with post-menopausal osteoporosis have impaired endothelial function.

Methods:

We used non-invasive Doppler ultrasound to assess endothelial function in sixty women with post-menopausal osteoporosis and compared results to 30 age, sex matched controls. After measurement of traditional cardiovascular risk factors, we measured flow mediated dilation (FMD) of the brachial artery in subjects. Flow mediated dilation is a dynamic assessment of endothelium-dependent and -independent dilation of an artery. Subjects were further assessed using radial artery tonometry. Isoprostane levels, which are a marker of oxidative stress, were compared between groups.

Results:

Groups were equally matched for age, weight, blood pressure, cholesterol profile and smoking history. Results from radial artery tonometry indicated that cardiac output (p=0.03), large artery elasticity index (p=0.03) and small artery elasticity index (p=0.03) readings were significantly higher in the healthy control group. Systemic vascular resistance (p=0.005) and total vascular impedance (p=0.032) was statistically significantly higher in patients with osteoporosis compared to controls. Flow mediated dilatation of the brachial artery showed a statistically significant better dilatation of the brachial artery post cuff deflation in healthy controls (p=0.006), although there was no difference in endothelium-independent dilation ie. brachial artery dilation after administration of GTN. Isoprostane levels were statistically significantly higher in the osteoporosis group

Conclusion:

The differences in flow mediated dilatation between healthy controls and post-menopausal women with osteoporosis may indicate impaired endothelial function and reflect the local distensibility of the brachial artery or the distal microcirculation’s response to the ischaemic stimulus. Radial artery tonometry results also support a difference in endothelial function between groups. Changes in vascular reactivity are likely to be multi-factorial but may be related in part to differences in levels of oxidative stress between groups. This study demonstrates that further work is required on the assessment of potential structural remodelling in small arteries and vascular beds that may precede clinically detectable cardiovascular disease in women with post-menopausal osteoporosis. Further work is also required on the complex interaction of common risk factors and genetic or molecular determinants of both conditions.


Disclosure:

A. M. Millar,
None;

A. McCann,
None;

V. McClenaghan,
None;

P. Hamilton,
None;

C. Bleakley,
None;

K. Lyons,
None;

G. McVeigh,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impaired-endothelial-function-in-post-menopausal-women-with-osteoporosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology